Reduced filaggrin expression is accompanied by increased Staphylococcus aureus colonization of epidermal skin models
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Summary: Background: Atopic dermatitis is an inflammatory skin disease that is characterized by a reduced skin barrier function, reduced filaggrin (FLG) expression as well as increased colonization by Staphylococcus aureus. Objective: This study focused on the possible involvement of FLG in epidermal colonization by S. aureus and/or whether it affects the epidermal defence mechanisms, including the expression of antimicrobial peptides (AMP s) and enzymes involved in stratum corneum barrier lipid synthesis. Furthermore, IL‐31 has been shown to reduce FLG expression, but its effects on bacterial colonization and on the expression of AMP s and enzymes involved in the barrier lipid synthesis are not known. Material and Methods: We established N/TERT‐based epidermal models (NEM s), after FLG knockdown (FLG‐KD) and/or cultured with IL‐31, that were colonized with S. aureus for 24 h. Results: Both FLG‐KD and IL‐31 supplementation resulted in significantly increased epidermal S. aureus colonization, as well as in an up‐regulation of S. aureus‐induced IL‐8 expression. IL‐31, but not FLG‐KD, prevented S. aureus‐induced up‐regulation of mRNA expression for the AMPs human β‐defensin 2 and ‐3 and RNAse7, whereas psoriasin expression remained unchanged. Furthermore, the S. aureus colonization induced changes in mRNA expression of ELOVL4 was not affected by FLG‐KD, but was blocked by IL‐31. Expression of SCD‐1 and Gcase mRNA was reduced by IL‐31, but not by FLG‐KD. Conclusion: This study shows that NEM s, with FLG‐KD and/or cultured in the presence of IL‐31, mimic the skin of patients with atopic dermatitis in several aspects, including enhanced bacterial colonization, increased inflammatory and reduced protective responses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Palmer, C. N. A., Irvine, A. D., Terron-Kwiatkowski, A., Zhao, Y., Liao, H., Lee, S. P., Goudie, D. R., Sandilands, A., Campbell, L. E., Smith, F. J. D., et al. (2006) · Nature Genetics · doi:10.1038/ng1767 · Cited by 2,978 · cited 1×
“To date, the association between AD and filaggrin (FLG) mutations is one of the strongest genotype linkage observed in complex human genetic disorders [4, 5].”
BackgroundJanssens, M., van Smeden, J., Gooris, G. S., Bras, W., Portale, G., Caspers, P. J., Vreeken, R. J., Hankemeier, T., Kezic, S., Wolterbeek, R., et al. (2012) · Journal of Lipid Research · doi:10.1194/jlr.p030338 · Cited by 488 · cited 1×
“aureus-induced changes in expression of enzymes involved in SC lipid synthesis [3, 37].”
BackgroundKezic, S., O’Regan, G. M., Yau, N., Sandilands, A., Chen, H., Campbell, L. E., Kroboth, K., Watson, R., Rowland, M., Irwin McLean, W. H., et al. (2011) · Allergy · doi:10.1111/j.1398-9995.2010.02540.x · Cited by 295
Mechanism of HBD-3 deficiency in atopic dermatitis
Howell, M. D., Boguniewicz, M., Pastore, S., Novak, N., Bieber, T., Girolomoni, G., & Leung, D. Y. M. (2006) · Clinical Immunology · doi:10.1016/j.clim.2006.08.008 · Cited by 208 · cited 1×
“While the Th2 cytokines, IL-4 and IL-13, have been shown to reduce the expression of the AMPs human b-defensin 2 and 3 (hBD-2 and hBD-3) in vitro, the effect of IL-31 on AMP expression and the innate immune response is still unknown [14, 15].”
Background
Cited by
Weidinger, S., & Novak, N. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00149-x · Cited by 1,908
Bacterial and Viral Infections in Atopic Dermatitis: a Comprehensive Review
Ong, P. Y., & Leung, D. Y. M. (2016) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-016-8548-5 · Cited by 281
Palmer, B., & DeLouise, L. (2016) · Molecules · doi:10.3390/molecules21121719 · Cited by 267
Genetic and epigenetic studies of atopic dermatitis
Bin, L., & Leung, D. Y. M. (2016) · Allergy, Asthma & Clinical Immunology · doi:10.1186/s13223-016-0158-5 · Cited by 242
Niehues, H., Bouwstra, J. A., El Ghalbzouri, A., Brandner, J. M., Zeeuwen, P. L. J. M., & van den Bogaard, E. H. (2018) · Experimental Dermatology · doi:10.1111/exd.13531 · Cited by 210
Immortalized N/TERT keratinocytes as an alternative cell source in 3D human epidermal models
Smits, J. P. H., Niehues, H., Rikken, G., van Vlijmen-Willems, I. M. J. J., van de Zande, G. W. H. J. F., Zeeuwen, P. L. J. M., Schalkwijk, J., & van den Bogaard, E. H. (2017) · Scientific Reports · doi:10.1038/s41598-017-12041-y · Cited by 205
Gonzalez, M. E., Schaffer, J. V., Orlow, S. J., Gao, Z., Li, H., Alekseyenko, A. V., & Blaser, M. J. (2016) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2016.04.066 · Cited by 195
Cytokine-Mediated Crosstalk Between Keratinocytes and T Cells in Atopic Dermatitis
Humeau, M., Boniface, K., & Bodet, C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.801579 · Cited by 75
Skin microbiota and human 3D skin models
Rademacher, F., Simanski, M., Gläser, R., & Harder, J. (2018) · Experimental Dermatology · doi:10.1111/exd.13517 · Cited by 64
Mieremet, A., Vázquez García, A., Boiten, W., van Dijk, R., Gooris, G., Bouwstra, J. A., & El Ghalbzouri, A. (2019) · Scientific Reports · doi:10.1038/s41598-019-44204-4 · Cited by 42
Skin microbiota analysis in human 3D skin models—“Free your mice”
Emmert, H., Rademacher, F., Gläser, R., & Harder, J. (2020) · Experimental Dermatology · doi:10.1111/exd.14164 · Cited by 32
Atopic Dermatitis: The Relationship Between Immune Mediators and Skin Lipid Barrier
You, H., & Liang, Y. (2025) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-025-09057-y · Cited by 17
Metadata
- Authors
- van Drongelen, V., Haisma, E. M., Out‐Luiting, J. J., Nibbering, P. H., & El Ghalbzouri, A.
- Venue
- Clinical & Experimental Allergy
- Publisher
- Wiley
- Published
- 2014-11-24
- Volume
- 44
- Issue
- 12
- Pages
- 1515-1524
- ISSN
- 0954-7894 (ISSN-L)
- 1365-2222
- OpenAlex
- W1969772342
- Cited by
- 101
- References
- 4
- FWCI
- 7.78
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.